These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 16388428

  • 21. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R.
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [Abstract] [Full Text] [Related]

  • 22. [Prevention of community-acquired pneumonia in adults].
    Barros M M, Cartagena S C, Bavestrello F L.
    Rev Chilena Infectol; 2005 Apr; 22 Suppl 1():s67-74. PubMed ID: 16163421
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [Abstract] [Full Text] [Related]

  • 24. [Respiratory pathology associated with pneumococcus].
    Léophonte P.
    Bull Acad Natl Med; 2002 Jun; 186(8):1439-54; discussion 1454-9. PubMed ID: 12669361
    [Abstract] [Full Text] [Related]

  • 25. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria.
    Falade AG, Lagunju IA, Bakare RA, Odekanmi AA, Adegbola RA.
    Clin Infect Dis; 2009 Mar 01; 48 Suppl 2():S190-6. PubMed ID: 19191615
    [Abstract] [Full Text] [Related]

  • 26. [Treatment and prevention of pneumococcal pneumonia].
    Léophonte P, Mazières J.
    Rev Prat; 2003 Sep 15; 53(13):1451-7. PubMed ID: 14558267
    [Abstract] [Full Text] [Related]

  • 27. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
    Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, Hennessy TW.
    J Infect Dis; 2006 Jun 01; 193(11):1487-94. PubMed ID: 16652275
    [Abstract] [Full Text] [Related]

  • 28. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F, Horcajada I, Cañas AM, Alamo I, Bordes A, González A, Santana M, Lafarga B.
    Enferm Infecc Microbiol Clin; 2009 Jan 01; 27(1):14-21. PubMed ID: 19217998
    [Abstract] [Full Text] [Related]

  • 29. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
    Flamaing J, Verhaegen J, Vandeven J, Verbiest N, Peetermans WE.
    J Antimicrob Chemother; 2008 Jan 01; 61(1):143-9. PubMed ID: 17999974
    [Abstract] [Full Text] [Related]

  • 30. Diagnosis of pneumococcal pneumonia.
    Palmer DL, Jones CC.
    Semin Respir Infect; 1988 Jun 01; 3(2):131-9. PubMed ID: 3041514
    [Abstract] [Full Text] [Related]

  • 31. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.
    Pediatr Infect Dis J; 2007 Sep 01; 26(9):771-7. PubMed ID: 17721369
    [Abstract] [Full Text] [Related]

  • 32. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ, Klugman KP, Pichichero M.
    Pediatr Infect Dis J; 2007 Feb 01; 26(2):123-8. PubMed ID: 17259873
    [Abstract] [Full Text] [Related]

  • 33. Pneumococcal pneumonia in hospitalized Uruguayan children and potential prevention with different vaccine formulations.
    Hortal M, Sehabiague G, Camou T, Iraola I, Estevan M, Pujadas M.
    J Pediatr; 2008 Jun 01; 152(6):850-3. PubMed ID: 18492530
    [Abstract] [Full Text] [Related]

  • 34. Pneumococcal vaccine development.
    Poolman JT.
    Expert Rev Vaccines; 2004 Oct 01; 3(5):597-604. PubMed ID: 15485339
    [Abstract] [Full Text] [Related]

  • 35. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R.
    Clin Infect Dis; 2008 Jan 15; 46(2):174-82. PubMed ID: 18171247
    [Abstract] [Full Text] [Related]

  • 36. The epidemiology of invasive Streptococcus pneumoniae disease in Croatian children.
    Guzvinec M, Tesović G, Tambić-Andrasević A, Zidovec-Lepej S, Vukić BT, Begovac J.
    Med Sci Monit; 2008 Dec 15; 14(12):PH59-64. PubMed ID: 19043375
    [Abstract] [Full Text] [Related]

  • 37. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H, ARIVAC Consortium.
    Vaccine; 2009 May 05; 27(20):2680-8. PubMed ID: 19428879
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR.
    Expert Rev Anti Infect Ther; 2008 Oct 05; 6(5):619-35. PubMed ID: 18847402
    [Abstract] [Full Text] [Related]

  • 39. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR, Good CE, Bajaksouzian S, Windau AR.
    Clin Infect Dis; 2008 Dec 01; 47(11):1388-95. PubMed ID: 18959493
    [Abstract] [Full Text] [Related]

  • 40. Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly.
    Ortqvist A, Henckaerts I, Hedlund J, Poolman J.
    Vaccine; 2007 Mar 22; 25(13):2445-50. PubMed ID: 17052816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.